STIOLTO RESPIMAT

Peak

tiotropium bromide and olodaterol

NDAINHALATIONSPRAY, METERED
Approved
May 2015
Lifecycle
Peak
Competitive Pressure
8/100

Mechanism of Action

olodaterol. The properties described below for the individual components apply to STIOLTO RESPIMAT. These drugs represent 2 different classes of medication (an anticholinergic and a beta-agonist) that have different effects on clinical and physiological indices. Tiotropium Tiotropium is a…

Loss of Exclusivity

LOE Date
Oct 16, 2030
56 months away
Patent Expiry
Oct 16, 2030

Patent Records (5)

Patent #ExpiryTypeUse Code
7396341
Oct 10, 2026
Product
7727984
Jan 19, 2027
Substance
9027967
Mar 31, 2027
Product
7396341*PED
Apr 10, 2027
7837235
Mar 13, 2028
Product